NR565 Week 4 Midterm Exam Review
Examplify Online Proctored Exam For
August 2nd 2026 Complete 100 Actual
exam Questions and Answer,s NR-565
Advanced Pharmacology Fundamentals |
100% Pass Guaranteed | Graded A+ |
Domain 1: Foundations of Pharmacology (Questions 1-30)
1. A patient is prescribed a drug that is a weak base with a pKa of
8.4. In which part of the body will this drug be most highly ionized?
• Answer: Stomach (pH 1.5–3.5)
• Rationale: Weak bases are more ionized in acidic environments
(low pH). In the stomach's acidic environment (pH 1.5-3.5), which
is well below the pKa of 8.4, the drug becomes highly ionized.
Ionized drugs are poorly absorbed across lipid membranes, which
has significant implications for both absorption and urinary
excretion.
,2. Which pharmacokinetic process is most affected by first-pass
metabolism?
• Answer: Oral absorption
• Rationale: First-pass metabolism occurs in the liver and gut wall
after oral administration, significantly reducing the amount of
active drug that reaches systemic circulation. Drugs with extensive
first-pass effect often require higher oral doses or alternative routes
of administration (such as sublingual, IV, or transdermal) to
achieve therapeutic levels.
3. A 70-year-old patient with heart failure is started on a new
medication with a high protein-binding affinity. Which
pharmacokinetic change related to aging most increases the risk of
toxicity?
• Answer: Decreased alpha-1-acid glycoprotein levels leading to
increased free drug fraction
• Rationale: Age-related decrease in serum albumin and alpha-1-
acid glycoprotein (AAG) levels leads to reduced protein binding
capacity. For highly protein-bound drugs, this results in a higher
free (unbound) drug fraction available to exert pharmacologic
effects and cause toxicity. This is particularly concerning in older
adults with polypharmacy.
,4. A patient is prescribed a drug that is a weak acid (pKa 4.4).
Where will this drug primarily be absorbed?
• Answer: Stomach (pH 1.5)
• Rationale: Weak acids are non-ionized (lipid-soluble) in acidic
environments, facilitating absorption across the gastric mucosa. In
the stomach's acidic environment (pH 1.5), which is below the pKa
of 4.4, the drug remains predominantly in its non-ionized,
absorbable form. As the drug moves into the small intestine (pH 6-
7), it becomes more ionized and less absorbable.
5. A patient with a genetic variation in CYP2D6 is prescribed
codeine for pain. The patient reports no relief. What is the most
likely mechanism?
• Answer: Poor metabolizer phenotype; unable to convert codeine to
morphine
• Rationale: CYP2D6 is responsible for converting the prodrug
codeine into its active metabolite, morphine. Patients with a poor
metabolizer phenotype have reduced or absent CYP2D6 enzyme
activity, preventing this conversion and resulting in inadequate
pain relief. Alternative analgesics not dependent on CYP2D6
metabolism (such as morphine directly) should be considered.
6. What is the purpose of a loading dose?
• Answer: Rapidly achieves drug levels in the therapeutic range
, • Rationale: A loading dose is a higher initial dose designed to
quickly achieve therapeutic drug concentrations. Following the
loading dose, a lower maintenance dose is administered to
maintain the drug within the therapeutic range. This approach is
particularly important for drugs with long half-lives where waiting
4-5 half-lives to reach steady state with maintenance dosing alone
would be clinically unacceptable.
7. Drugs that have a significant first-pass effect:
• Answer: Are rapidly metabolized by the liver and may have little
if any desired action when taken orally
• Rationale: Drugs with extensive first-pass metabolism undergo
significant biotransformation in the liver and gut wall before
reaching systemic circulation. This can substantially reduce oral
bioavailability, sometimes to the point where oral administration is
ineffective. Such drugs often require alternative routes (e.g.,
sublingual, IV, transdermal) to achieve therapeutic effects.
8. The route of excretion of a volatile drug will likely be the:
• Answer: Lungs
• Rationale: Volatile drugs, such as volatile anesthetics and some
alcohols, are primarily eliminated through exhalation via the lungs.
This route of elimination is unique among drugs and is an
important consideration for drugs administered via inhalation or
those with volatile properties.
Examplify Online Proctored Exam For
August 2nd 2026 Complete 100 Actual
exam Questions and Answer,s NR-565
Advanced Pharmacology Fundamentals |
100% Pass Guaranteed | Graded A+ |
Domain 1: Foundations of Pharmacology (Questions 1-30)
1. A patient is prescribed a drug that is a weak base with a pKa of
8.4. In which part of the body will this drug be most highly ionized?
• Answer: Stomach (pH 1.5–3.5)
• Rationale: Weak bases are more ionized in acidic environments
(low pH). In the stomach's acidic environment (pH 1.5-3.5), which
is well below the pKa of 8.4, the drug becomes highly ionized.
Ionized drugs are poorly absorbed across lipid membranes, which
has significant implications for both absorption and urinary
excretion.
,2. Which pharmacokinetic process is most affected by first-pass
metabolism?
• Answer: Oral absorption
• Rationale: First-pass metabolism occurs in the liver and gut wall
after oral administration, significantly reducing the amount of
active drug that reaches systemic circulation. Drugs with extensive
first-pass effect often require higher oral doses or alternative routes
of administration (such as sublingual, IV, or transdermal) to
achieve therapeutic levels.
3. A 70-year-old patient with heart failure is started on a new
medication with a high protein-binding affinity. Which
pharmacokinetic change related to aging most increases the risk of
toxicity?
• Answer: Decreased alpha-1-acid glycoprotein levels leading to
increased free drug fraction
• Rationale: Age-related decrease in serum albumin and alpha-1-
acid glycoprotein (AAG) levels leads to reduced protein binding
capacity. For highly protein-bound drugs, this results in a higher
free (unbound) drug fraction available to exert pharmacologic
effects and cause toxicity. This is particularly concerning in older
adults with polypharmacy.
,4. A patient is prescribed a drug that is a weak acid (pKa 4.4).
Where will this drug primarily be absorbed?
• Answer: Stomach (pH 1.5)
• Rationale: Weak acids are non-ionized (lipid-soluble) in acidic
environments, facilitating absorption across the gastric mucosa. In
the stomach's acidic environment (pH 1.5), which is below the pKa
of 4.4, the drug remains predominantly in its non-ionized,
absorbable form. As the drug moves into the small intestine (pH 6-
7), it becomes more ionized and less absorbable.
5. A patient with a genetic variation in CYP2D6 is prescribed
codeine for pain. The patient reports no relief. What is the most
likely mechanism?
• Answer: Poor metabolizer phenotype; unable to convert codeine to
morphine
• Rationale: CYP2D6 is responsible for converting the prodrug
codeine into its active metabolite, morphine. Patients with a poor
metabolizer phenotype have reduced or absent CYP2D6 enzyme
activity, preventing this conversion and resulting in inadequate
pain relief. Alternative analgesics not dependent on CYP2D6
metabolism (such as morphine directly) should be considered.
6. What is the purpose of a loading dose?
• Answer: Rapidly achieves drug levels in the therapeutic range
, • Rationale: A loading dose is a higher initial dose designed to
quickly achieve therapeutic drug concentrations. Following the
loading dose, a lower maintenance dose is administered to
maintain the drug within the therapeutic range. This approach is
particularly important for drugs with long half-lives where waiting
4-5 half-lives to reach steady state with maintenance dosing alone
would be clinically unacceptable.
7. Drugs that have a significant first-pass effect:
• Answer: Are rapidly metabolized by the liver and may have little
if any desired action when taken orally
• Rationale: Drugs with extensive first-pass metabolism undergo
significant biotransformation in the liver and gut wall before
reaching systemic circulation. This can substantially reduce oral
bioavailability, sometimes to the point where oral administration is
ineffective. Such drugs often require alternative routes (e.g.,
sublingual, IV, transdermal) to achieve therapeutic effects.
8. The route of excretion of a volatile drug will likely be the:
• Answer: Lungs
• Rationale: Volatile drugs, such as volatile anesthetics and some
alcohols, are primarily eliminated through exhalation via the lungs.
This route of elimination is unique among drugs and is an
important consideration for drugs administered via inhalation or
those with volatile properties.
